The breakthroughs we're seeing in psychedelic medicine today started with non-profit organizations taking risks that others wouldn't.
Three organizations leading the charge are Multidisciplinary Association for Psychedelic Studies (MAPS), OPEN Foundation and Champalimaud Foundation.
Psychedelic research faces unique hurdles, such as Schedule I drug classification, complex regulatory requirements, and historical stigma. Traditional funding sources (pharma, government and academia) often avoid these high-risk, long-term investments, which is where non-profits can make big strides.
They tend to be mission-driven, patient-focused, and have a long-term commitment to research.
Check out my latest Nina's Note to learn how these organizations push psychedelic research forward and act as bridge-builders between science and public understanding.
💬 In this note:
🏢 Non-Profit Organizations Are the Hidden Heroes Advancing Psychedelic Science
🎧 DOAC: The Happiness Expert
⚡️ Physical Exercise Helps Neurons Grow
